Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Depreciation & Amortization (CF) (2016 - 2022)

Historic Depreciation & Amortization (CF) for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q4 2022 value amounting to $586000.0.

  • Avadel Pharmaceuticals' Depreciation & Amortization (CF) rose 19154.23% to $586000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $1.5 million, marking a year-over-year increase of 8319.02%. This contributed to the annual value of $2.7 million for FY2024, which is 5181.2% up from last year.
  • As of Q4 2022, Avadel Pharmaceuticals' Depreciation & Amortization (CF) stood at $586000.0, which was up 19154.23% from $401000.0 recorded in Q3 2022.
  • Avadel Pharmaceuticals' 5-year Depreciation & Amortization (CF) high stood at $2.0 million for Q1 2018, and its period low was $197000.0 during Q3 2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $695700.0, with a median of $428500.0 in 2020.
  • In the last 5 years, Avadel Pharmaceuticals' Depreciation & Amortization (CF) crashed by 8141.06% in 2019 and then soared by 19154.23% in 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Depreciation & Amortization (CF) (Quarter) stood at $1.8 million in 2018, then tumbled by 55.9% to $796000.0 in 2019, then plummeted by 50.63% to $393000.0 in 2020, then crashed by 48.85% to $201000.0 in 2021, then surged by 191.54% to $586000.0 in 2022.
  • Its Depreciation & Amortization (CF) stands at $586000.0 for Q4 2022, versus $401000.0 for Q3 2022 and $247000.0 for Q2 2022.